Floatz logo

Sebelipase Alfa

Wolman Disease

Alexion Pharmaceuticals, Inc.protein_peptidePhase 2/3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Wolman Disease cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
Anti-Thymoglobulin, Rabbit
Masonic Cancer Center, University of Minnesota
Phase 2/3B
Clofarabine
Masonic Cancer Center, University of Minnesota
Phase 2B
Evomela
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 10 →

Same molecule, other indications

Sebelipase Alfa is also rated in:

lysosomal acid lipase deficiencyDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →